Czechia· CZ-0241409

INHIBACE PLUS

A cilazapril und diuretika product containing cilazapril monohydrate + hydrochlorothiazide, registered in Czechia by CHEPLAPHARM Arzneimittel GmbH, Greifswald. The same ATC class is registered in 6 of our 19 countries.

ATC C09BA08

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedINHIBACE PLUSATCC09BA08REGISTER NO.CZ-0241409PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Cilazapril und diuretika is registered in 6 of 19 countries.

Countries holding a registration under ATC C09BA08 (cilazapril und diuretika), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 5 of them publish a price we can compare per daily dose

Cilazapril und diuretika · ATC C09BA08

6 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
CILAZAPRIL MONOHYDRATE + HYDROCHLOROTHIAZIDE
Manufacturer
CHEPLAPHARM Arzneimittel GmbH, Greifswald
Country
Czechia (CZ)
ATC code
C09BA08
ATC class
Cilazapril und Diuretika
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

67 interactions on record for cilazapril und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cilazapril und diuretika · interactions on record

67 records

67 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Cilazapril und diuretika in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cilazapril und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Inhibace Plus
  • Belgium · Co-Inhibace
  • Germany · Dynorm Plus
  • Spain · Inhibace Plus
  • Greece · Vascace Plus
  • Hungary · Inhibace Plus
  • Italy · Inibace Plus, Initiss Plus
  • Poland · Inhibace Plus
  • Portugal · Cilazapril + Hidroclorotiazida Generis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/37f62f28-2dc8-4a25-b454-d4476e197387
GET /v1/drugs/37f62f28-2dc8-4a25-b454-d4476e197387?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "5MG/12,5MG",
  "pack_size": "28",
  "substance": "CILAZAPRIL MONOHYDRATE + HYDROCHLOROTHIAZIDE",
  "cz_kod_sukl": "0241409",
  "product_type": "CH",
  "substance_codes": "12895,728",
  "registration_state": "R",
  "registration_number": "58/181/03-C"
}

See everything about cilazapril und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.